NINDS Neuroscience Funding Announcements

The National Institute of Neurological Disorders and Stroke (NINDS), NIH has a requirement in support of a program that will require provision for medicinal chemistry services. The NINDS envisions awarding a contract for medicinal chemistry services as part of a new Medicinal Chemistry for Neurotherapeutics Program (MCNP), which is designed to help overcome barriers to drug development for diseases that affect the nervous system. The MCNP is part of an overall NIH Blueprint Network program initiative.